Catalyst Wire Dossier Catalyst Wire Dossier

Vidaza (azacitidine)

azacitidine · Celgene/BMS
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Vidaza (azacitidine), covering 2011-01-24 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia [Phase 2]

See pricing